Vaccines do not contribute to multiple sclerosis or other central nervous system demyelinating syndrome onset, according to a study published in JAMA Neurology.
Ann Romney announced the launch of a neurologic center in collaboration with Brigham and Women’s Hospital in Boston, set to open in 2016.
Calculation and interpretation of the anion gap is extremely useful in the evaluation and treatment of the patient with metabolic acidosis. In this installment, we look at case examples involving patients with multiple sclerosis and urosepsis; COPD, diabetes, and renal failure; and type 1 diabetes.
Inflammatory bowel diseases have an impact on the prognosis of multiple sclerosis, according to a study published in PLOS One.
The US Food and Drug Administration (FDA) approved Genzyme’s application to include new information about its multiple sclerosis drug teriflunomide (Aubagio) on its label. The new labeling content is efficacy and safety data from two Phase III trials of the drug.
The body’s immune system can be “taught” not to attack its own cells, such as in the case of multiple sclerosis, according to research published in Nature Communications.